Future of Management of Multiple Sclerosis in the Middle East: A Consensus View from Specialists in Ten Countries

by Mohammed Aljumah, Raed Alroughani, I. Alsharoqi, Saeed A. Bohlega, Maurice Dahdaleh, Dirk Deleu, Khaled Esmat, Ahmad Khalifa, Mohammad A. Sahraian, Miklós Szólics, Abdulrahman AlTahan, Bassem I. Yamout, Peter Rieckmann, Abdulkader Daif
Published 2013-01-01

A Prospective Multicenter Study for Assessing MusiQoL Validity among Arabic-Speaking MS Patients Treated with Subcutaneous Interferon β-1a

by Mohammed Al Jumah, Suleiman Kojan, Raed Alroughani, Edward Cupler, Saeed Bohlega, Abdulkader Daif, Mousa Al Mujalli, Talal Al Harbi, Mohamed El Tamawy, Samia Ashour, Chokri Mhiri, Riadh Gouider, Ayah Jawhary, Ahmed El Boghdady, Mohamed Hussein
Published 2021-01-01

Cladribine Tablets and Relapsing–Remitting Multiple Sclerosis: A Pragmatic, Narrative Review of What Physicians Need to Know

by Mohamed AlJumah, Mona Marwan Alkhawajah, Shireen Qureshi, Ibtisam Al-Thubaiti, Omar Ayoub, Saeed A. Bohlega, Areej Bushnag, Edward Cupler, Abdulkader Daif, Ahmed El Boghdady, Ahmed Hassan, Yaser Al Malik, Jameelah Saeedi, Fawzia Al-Shamrany, Eslam Shosha, Peter Rieckmann
Published 2020-02-01

Pregnancy and the Use of Disease-Modifying Therapies in Patients with Multiple Sclerosis: Benefits versus Risks

by Raed Alroughani, Ayse Altintas, Mohammed Al Jumah, Mohammadali Sahraian, Issa Alsharoqi, Abdurahman AlTahan, Abdulkader Daif, Maurice Dahdaleh, Dirk Deleu, Oscar Fernandez, Nikolaos Grigoriadis, Jihad Inshasi, Rana Karabudak, Karim Taha, Natalia Totolyan, Bassem I. Yamout, Magd Zakaria, Saeed Bohlega
Published 2016-01-01